Assyro AI

Orange Book product · Brand (NDA)

TRIFERIC

FERRIC PYROPHOSPHATE CITRATE

Brand (NDA)NDA 208551DISCN ROCKWELL MEDICAL INC

At a glance

Apr 25, 2016

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 25, 2016

    10 yr 4 mo ago

  2. Today

  3. Patent 7857977 expires

    Listed method-of-use patent (U-1656) expiration.

    Sep 08, 2027

    in 1 yr 3 mo

  4. Patent 7816404 expires

    Listed method-of-use patent (U-1656) expiration.

    Apr 17, 2029

    in 2 yr 10 mo

Pharmaceutical detail

Active ingredient

FERRIC PYROPHOSPHATE CITRATE

Strength

272MG IRON/PACKET

Dosage form

POWDER

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 208551

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7857977Sep 08, 2027in 1 yr 3 mo
U-1656
7816404Apr 17, 2029in 2 yr 10 mo
U-1656
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.